ProMIS Neurosciences, Inc. (NASDAQ:PMN – Get Free Report)’s share price fell 3% during trading on Thursday . The stock traded as low as $1.61 and last traded at $1.61. 3,175 shares changed hands during trading, a decline of 33% from the average session volume of 4,774 shares. The stock had previously closed at $1.66.
ProMIS Neurosciences Price Performance
The company has a market capitalization of $30.53 million, a P/E ratio of -2.18 and a beta of 0.65. The company has a fifty day simple moving average of $1.74 and a two-hundred day simple moving average of $1.85.
ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) last posted its quarterly earnings data on Tuesday, May 14th. The company reported ($0.19) earnings per share for the quarter. Equities analysts anticipate that ProMIS Neurosciences, Inc. will post -1.11 earnings per share for the current year.
ProMIS Neurosciences Company Profile
ProMIS Neurosciences, Inc discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.
Read More
- Five stocks we like better than ProMIS Neurosciences
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 Healthcare Dividend Stocks to Buy
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for ProMIS Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMIS Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
